Hide Board Information

Show Board Information

SOCIETE GENERALE ACCEPTANCE NV CALL WTS 20/6/08STAN E0.1 GBX2000 C SO23

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:30 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

SOCIETE GENERALE ACCEPTANCE NV CALL WTS 20/6/08STAN E0.1 GBX2000 C (SO23) Stock Message Board

Find SO23 Recent News, SO23 Filings, SO23 Stock Quote, SO23 Stock Chart, SO23 Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on SOCIETE GENERALE ACCEPTANCE NV CALL WTS 20/6/08STAN E0.1 GBX2000 C SO23

Recent Articles

• Alithya Deepens Microsoft Expertise with XRM Vision Deal
• Syharvest Aluminum Innovates Amid Export Tax Rebate Changes
• Sandvik Expands Capabilities with Universal Field Robots Buyout
• IREN Limited Boosts Bitcoin Mining Capacity by 33% to 28 EH/s
• OSB Group PLC Voting Rights Information and Updates
• IHS Towers and Zain Group Partner for Strategic Sale in Kuwait
• Core Scientific Explores $500 Million Senior Notes Offering
• WellBe Senior Medical Enhances Leadership With New Executives
• Syharvest Aluminum's Strategic Response to Export Tax Changes
• AdvantageClub.ai Secures $4 Million Funding to Drive Growth
• Empowering Women in Tech: DMZ's Innovation Summit 2025
• Quaternary Ammonium Salts Market Expanding: Insights Ahead
• Digihost Reports Strong Revenue Growth and Expansion Plans
• TRX Gold Celebrates Successful Year-End Results and Growth
• Kronos Advanced Technologies Unveils Holiday Air Purifier Deals
• Pandora Executes Significant Share Buyback Initiative
• Benedicte Schilbred Fasmer Takes the Helm at Telenor
• Agora, Inc.'s Management Announces New Lock-Up Commitment
• Immuron's CEO to Showcase Innovations at Upcoming Investor Event
• DeepHealth Unveils Innovative AI Solutions for Medical Imaging
• LNG Energy Group Shares Q3 Performance Insights and Updates
• Innovative UAV Collaboration Sparks Growth in Aerospace Sector
• Apogee Therapeutics Unveils Breakthrough Insights in Biologics
• Critical Need for U.S. LNG to Support Asia's Energy Transition
• Ducommun's Strategic Insights at Upcoming Industry Conference
• RadNet, Inc. Set to Showcase Innovations at Finance Forum
• Revelation Biosciences Achieves Key FDA Milestone for Gemini IND
• FAT Brands Inc. Engages at Noble Capital Markets Conference
• Oscar Mayer Celebrates 50 Years of Bologna Jingle Revival
• SEACOR Marine Secures Major Financing and Fleet Expansion Plans
• U-Haul Enhances Local Storage Solutions with New Facility
• Aramco Strengthens Partnership with Horse Powertrain via Stake
• Stronghouse Solutions Welcomes Russ Reynolds as CEO for Growth
• Lead the Charge: Edwards Lifesciences Shareholders Unite
• Redwire Corporation Enhances European Reach with New Office
• Explore December Insights: Supply Chain and Procurement Trends
• Outstanding Agents from Berkshire Hathaway Recognized in 2024
• IDEAYA Biosciences Engages Investors at Upcoming Conferences
• Enigma Biomedical USA Unveils Scientific Advisory Board for Progress
• QinetiQ US Secures $42M Task Order to Enhance Army Capabilities
• Celsius Holdings Inc: Important Class Action Lawsuit Details
• High Tide Enhances Cabana Club Membership for Global Reach
• Key Insights on Rentokil Initial plc Class Action Opportunity
• Soft N Dry Diaper Enhances Sales Strategy with New Appointment
• Evernest Strengthens Market Position with New Acquisition
• Ricky Wright Returns to Inspire Growth at Alkaline Company
• Dynepic Introduces MOTAR Ghost to Enhance Security for Enterprises
• Shawmut Design and Construction Grows Large Project Division
• MY DR NOW Launches Innovative Clinic for Community Care
• Empowering Education: reDesign's CBE Catalyst Launch